Back

True rate of drug-related adverse effects on potassium homeostasis of the renin angiotensin aldosterone system inhibitors in placebo controlled trials: a meta-analysis

30 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Heart failure / Left ventricular dysfunction Pharmacologic therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Davor Vukadinovic

Saarland University Hospital, Homburg (Germany)

49 More presentations in this session

Presentation thumbnail
Professor H. Duengen (Berlin, DE)
Presentation thumbnail
Doctor T. Mondritzki (Wuppertal, DE)
Abstract Slides
Presentation thumbnail
Doctor A. Ruwald (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Associate Professor N. Ermis (Malatya, TR)
Abstract Slides
Presentation thumbnail
Professor S. Nie (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Heart failure / Left ventricular dysfunction

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients
29 June 2021
thumbnail
Congress Presentation
Plasma aldosterone concentration / plasma renin activity ratio in patients with essential hypertension before treatment
26 August 2023
thumbnail
Congress Presentation
Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107
28 August 2022
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources